SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., March 28, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced topline...
Hence then, the article about shanton reveals topline data from phase 2b study in refractory gout patients was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Patients )
Also on site :
- Today's NYT Mini Crossword Answers for April 29 – CNET
- Amazon’s $35 Seersucker Comforter Set Has a 'Cloud-Like Feel' That 'Makes You Want to Stay in Bed All Day'
- MI vs SRH Dream11 Prediction Today Match, Dream11 Team Today, Fantasy Cricket Tips, Playing XI, Pitch Report, Injury Update- IPL 2026, Match 41